GAUTENG. – Steve Biko Akademiese Hospitaal in Pretoria het op 17 Januarie die eerste krioablasieprosedure in Suid-Afrika se openbare gesondheidsorgsektor suksesvol uitgevoer, wat die instelling as ’n voorloper van gevorderde, minimaal indringende behandeling posisioneer. Krioablasie is ’n mediese prosedure wat gebruik maak van uiterste koue om kankerselle of abnormale weefsel te vernietig.
Die hospitaal sê in ‘n sosialemediaplasing die prosedure, wat deur ’n multidissiplinêre span spesialisradioloë en uroloë uitgevoer is, behels die vernietiging van abnormale weefsel deur dit teen uiters lae temperature te vries. Volgens die Gautengse departement van gesondheid bied die tegniek voordele soos minder pyn, korter hospitaalverblyf en vinniger herstel in vergelyking met oop chirurgie.
Die hospitaal sê die ingreep is verder ondersteun deur internasionale kundigheid wat regstreeks virtueel by die prosedure betrokke was – wat die gebruik van digitale gesondheidstegnologie in openbare sorg beklemtoon. Die suksesvolle uitvoer van die prosedure word gesien as ’n stap vorentoe om toegang tot gespesialiseerde sorg binne die openbare sektor uit te brei.
Lees meer hier onder:
Steve Biko Academic Hospital Performs First Cryoablation in South Africa’s Public Health Sector
Pretoria, 17 January 2026 — Steve Biko Academic Hospital has entered a new chapter in South African public healthcare after successfully performing its first cryoablation procedure, a milestone that positions the institution as the first public hospital in the country to introduce this advanced, minimally invasive treatment.
The procedure, carried out at the Pretoria-based academic hospital, represents a significant step forward in the provision of specialised and super-specialised care within the Gauteng Department of Health.Cryoablation is a medical technique that destroys abnormal tissue, including cancer, by freezing it at extremely low temperatures, and is widely regarded internationally as a precise, patient-friendly alternative to conventional surgery for selected tumours.
The pioneering case was performed by specialist radiologists Prof Van Der Walt, Dr Rodney Maseko and Dr Riaan Potgieter, working under the leadership of Professor Zarina Lockhat. They were joined by urologists Dr Guy Gaudji and Dr Raymond Campbell, under the leadership of Professor Kgomotso Mathabe, reflecting a multidisciplinary approach that is central to modern interventional medicine.
Cryoablation involves the percutaneous insertion of thin probes into the target tissue under image guidance, typically using CT or ultrasound. Once correctly positioned, the probes release bursts of argon gas that rapidly lower temperatures to below –40°C, forming a clearly visible “ice ball” that envelops and destroys abnormal cells while sparing surrounding healthy structures. The ability to visualise the treatment zone in real time allows clinicians to achieve exceptional accuracy, particularly when lesions are located near critical organs or blood vessels.
Compared with open surgery, cryoablation offers substantial benefits for patients, including reduced pain, minimal blood loss, shorter hospital stays, and faster recovery times. These advantages are especially important in public healthcare settings, where reducing complications and length of admission can significantly ease pressure on already stretched resources.
Adding a further layer of innovation to the procedure was the use of remote international expertise. Dr Matthias Feurstner (MD, EBIR-IO, EMBA), an experienced interventional radiologist based in Austria, served as the proctor for the case. Through real-time virtual supervision, he guided the local team throughout the procedure. Dr Potgieter wore Google Smart Glasses, enabling live visual communication with the off-site proctor an advanced application of digital health technology that underscores the growing role of global collaboration in modern medicine.
Hospital leadership has described the achievement as a testament to the skill, dedication, and forward-thinking mindset of the clinical teams involved. It also reflects sustained strategic investment by the Gauteng Department of Health in high-impact technologies that expand access to world-class care within the public sector.
Beyond the walls of Steve Biko Academic Hospital, the successful introduction of cryoablation carries broader significance. It signals a shift towards more equitable access to cutting-edge treatments traditionally limited to private healthcare, and reinforces the role of academic public hospitals as drivers of innovation, training, and research.
As South Africa’s public health system continues to confront complex disease burdens and resource constraints, milestones such as this demonstrate how targeted investment, multidisciplinary expertise, and intelligent use of technology can translate into tangible improvements in patient care.
Videokrediet: Kyle Kotze, Boston Scientific
